Global /United States /Healthcare /Drug Manufacturers - General /TTRX

Turn Therapeutics Inc.

TTRX

• NASDAQ: TTRX • Delayed

3.56USD -1.3%

As of 16 June 2026, Turn Therapeutics Inc. has a market cap of $105.9M USD, ranking #25145 globally and #3881 in the United States. It ranks #2252 in the Healthcare sector, and #819 in the Drug Manufacturers - General industry.

Global Rank

25145

Country Rank

3881

Sector Rank

2252

Industry Rank

819

Key Stats

Market Cap

$105.9MUSD

Enterprise Value

$100.9MUSD

EBITDA (TTM)

-$6.3MUSD

Net Income (TTM)

-$3.19MUSD

PB Ratio

22.3

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bradley Burnam open_in_new

Employees

Founded

2015

Website

turntherapeutics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	6.1%	2.7%	-22%	-32%	-9.8%	-74%	-74%	-74%

News

TTRX Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	TTRX ISIN: US90021W1053 Shares Out.: Shares Outstanding: 29.788M¹ Shares Float: 10.788M² TV: TradingView: NASDAQ: TTRX SA: Stock Analysis: NASDAQ: TTRX YF: Yahoo Finance: TTRX GF: Google Finance: NASDAQ: TTRX NQ: NASDAQ: TTRX BA: Barron's: TTRX MS: Morningstar: XNAS: TTRX	3.56 USD	TV: TradingView: NASDAQ: TTRX SA: Stock Analysis: NASDAQ: TTRX YF: Yahoo Finance: TTRX GF: Google Finance: NASDAQ: TTRX NQ: NASDAQ: TTRX BA: Barron's: TTRX MS: Morningstar: XNAS: TTRX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Turn Therapeutics Inc.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Similar Companies

Industry: Drug Manufacturers - General (United States)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 719K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 517K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 340K%	97.4	United States
Merck & Co., Inc. NYSE: MRK	$274.03B 259K%	15.1	United States
Pfizer Inc. NYSE: PFE	$149.38B 141K%	19.5	United States
Bristol-Myers Squibb Co. NYSE: BMY	$117.58B 111K%	16.8	United States

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 303K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 272K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$273.78B 218.9B CHF 258K%	20.5	Switzerland
Novo Nordisk A/S CPH: NOVO-B	$181.97B 1.18T DKK 172K%	11.5	Denmark
Sanofi EPA: SAN	$110.21B 95.26B EUR 104K%	19.9	France
GSK plc LSE: GSK	$108.2B 80.96B GBP 102K%	14.6	United Kingdom

chevron_leftBack